nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—ADRB2—autistic disorder	0.895	1	CbGaD
Formoterol—Isoprenaline—MAPK1—autistic disorder	0.0025	0.207	CrCbGaD
Formoterol—Dobutamine—COMT—autistic disorder	0.00207	0.171	CrCbGaD
Formoterol—Fenoterol—ADRB2—autistic disorder	0.00129	0.106	CrCbGaD
Formoterol—Ritodrine—ADRB2—autistic disorder	0.00129	0.106	CrCbGaD
Formoterol—Arbutamine—ADRB2—autistic disorder	0.0012	0.0994	CrCbGaD
Formoterol—Arformoterol—ADRB2—autistic disorder	0.00117	0.0965	CrCbGaD
Formoterol—Dobutamine—ADRB2—autistic disorder	0.00111	0.0915	CrCbGaD
Formoterol—Labetalol—ADRB2—autistic disorder	0.000853	0.0705	CrCbGaD
Formoterol—Isoprenaline—ADRB2—autistic disorder	0.000628	0.0519	CrCbGaD
Formoterol—CYP2A6—Metabolism—RORA—autistic disorder	4.68e-05	0.000504	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—UPB1—autistic disorder	4.65e-05	0.000502	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—EXT1—autistic disorder	4.64e-05	0.0005	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC6A8—autistic disorder	4.64e-05	0.0005	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	4.56e-05	0.000492	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	4.53e-05	0.000489	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—DAO—autistic disorder	4.46e-05	0.000481	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	4.43e-05	0.000478	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—DAO—autistic disorder	4.43e-05	0.000477	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MAOB—autistic disorder	4.38e-05	0.000473	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VIP—autistic disorder	4.38e-05	0.000472	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GRM5—autistic disorder	4.38e-05	0.000472	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM5—autistic disorder	4.33e-05	0.000466	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ASMT—autistic disorder	4.33e-05	0.000466	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	4.29e-05	0.000462	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GRM5—autistic disorder	4.28e-05	0.000462	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VIP—autistic disorder	4.28e-05	0.000462	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—UPB1—autistic disorder	4.28e-05	0.000461	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—UPB1—autistic disorder	4.24e-05	0.000457	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OXTR—autistic disorder	4.24e-05	0.000457	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SCT—autistic disorder	4.2e-05	0.000452	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	4.19e-05	0.000452	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OXTR—autistic disorder	4.15e-05	0.000447	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	4.14e-05	0.000447	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SCT—autistic disorder	4.1e-05	0.000443	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—TPH2—autistic disorder	4.08e-05	0.000439	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC25A12—autistic disorder	4.07e-05	0.000439	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—DPYD—autistic disorder	4.01e-05	0.000432	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4e-05	0.000432	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADM—autistic disorder	4e-05	0.000432	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM5—autistic disorder	3.98e-05	0.000429	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ASMT—autistic disorder	3.98e-05	0.000429	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC19A1—autistic disorder	3.96e-05	0.000427	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ASMT—autistic disorder	3.94e-05	0.000425	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM5—autistic disorder	3.94e-05	0.000425	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	3.93e-05	0.000424	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	3.92e-05	0.000422	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADM—autistic disorder	3.92e-05	0.000422	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	3.9e-05	0.000421	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AVP—autistic disorder	3.89e-05	0.00042	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	3.85e-05	0.000415	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	3.82e-05	0.000411	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AVP—autistic disorder	3.81e-05	0.00041	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	3.78e-05	0.000407	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC25A12—autistic disorder	3.74e-05	0.000403	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CACNA1C—autistic disorder	3.73e-05	0.000402	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC25A12—autistic disorder	3.71e-05	0.0004	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	3.7e-05	0.000398	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	3.66e-05	0.000395	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC19A1—autistic disorder	3.64e-05	0.000392	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	3.64e-05	0.000392	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC19A1—autistic disorder	3.61e-05	0.000389	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	3.58e-05	0.000386	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	3.57e-05	0.000384	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADSL—autistic disorder	3.53e-05	0.00038	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	3.49e-05	0.000376	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—XDH—autistic disorder	3.46e-05	0.000373	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—GZMB—autistic disorder	3.46e-05	0.000373	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—NPAS2—autistic disorder	3.39e-05	0.000366	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—STX1A—autistic disorder	3.39e-05	0.000366	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—DHFR—autistic disorder	3.39e-05	0.000366	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—GZMB—autistic disorder	3.38e-05	0.000364	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OXT—autistic disorder	3.35e-05	0.000362	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	3.35e-05	0.000362	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	3.32e-05	0.000357	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OXT—autistic disorder	3.28e-05	0.000354	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	3.28e-05	0.000354	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TCN2—autistic disorder	3.28e-05	0.000353	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADSL—autistic disorder	3.24e-05	0.00035	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.24e-05	0.000349	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADSL—autistic disorder	3.22e-05	0.000347	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—XDH—autistic disorder	3.18e-05	0.000343	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.17e-05	0.000342	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—XDH—autistic disorder	3.15e-05	0.00034	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADA—autistic disorder	3.13e-05	0.000337	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.13e-05	0.000337	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—STX1A—autistic disorder	3.12e-05	0.000337	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NPAS2—autistic disorder	3.12e-05	0.000337	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.12e-05	0.000336	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.12e-05	0.000336	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—STX1A—autistic disorder	3.1e-05	0.000334	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NPAS2—autistic disorder	3.1e-05	0.000334	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	3.09e-05	0.000333	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.06e-05	0.00033	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.05e-05	0.000329	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.05e-05	0.000329	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.03e-05	0.000327	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.02e-05	0.000326	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TCN2—autistic disorder	3.02e-05	0.000325	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	2.99e-05	0.000323	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TCN2—autistic disorder	2.99e-05	0.000322	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	2.97e-05	0.00032	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.96e-05	0.000319	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL5—autistic disorder	2.96e-05	0.000319	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD3—autistic disorder	2.95e-05	0.000319	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	2.93e-05	0.000316	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CALCA—autistic disorder	2.92e-05	0.000315	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL5—autistic disorder	2.89e-05	0.000312	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADA—autistic disorder	2.88e-05	0.00031	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CALCA—autistic disorder	2.86e-05	0.000308	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—RORA—autistic disorder	2.85e-05	0.000308	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADA—autistic disorder	2.85e-05	0.000307	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	2.85e-05	0.000307	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	2.84e-05	0.000306	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.82e-05	0.000304	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	2.79e-05	0.0003	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	2.78e-05	0.000299	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	2.72e-05	0.000293	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.7e-05	0.000291	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MAOB—autistic disorder	2.67e-05	0.000288	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	2.66e-05	0.000287	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP19A1—autistic disorder	2.66e-05	0.000286	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—RORA—autistic disorder	2.62e-05	0.000283	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—RORA—autistic disorder	2.6e-05	0.00028	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—POMC—autistic disorder	2.59e-05	0.000279	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRL—autistic disorder	2.58e-05	0.000278	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.54e-05	0.000274	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—POMC—autistic disorder	2.53e-05	0.000273	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRL—autistic disorder	2.52e-05	0.000272	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TPH2—autistic disorder	2.48e-05	0.000268	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—COMT—autistic disorder	2.47e-05	0.000266	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MAOB—autistic disorder	2.46e-05	0.000265	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTP1—autistic disorder	2.46e-05	0.000265	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MAOA—autistic disorder	2.45e-05	0.000264	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	2.45e-05	0.000264	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—DPYD—autistic disorder	2.44e-05	0.000264	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MAOB—autistic disorder	2.44e-05	0.000263	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAT—autistic disorder	2.39e-05	0.000258	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.32e-05	0.00025	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.3e-05	0.000248	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.3e-05	0.000248	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.29e-05	0.000247	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TPH2—autistic disorder	2.29e-05	0.000246	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CACNA1C—autistic disorder	2.27e-05	0.000245	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TPH2—autistic disorder	2.27e-05	0.000244	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GSTM1—autistic disorder	2.26e-05	0.000243	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PLA2G4A—autistic disorder	2.26e-05	0.000243	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.25e-05	0.000242	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—DPYD—autistic disorder	2.25e-05	0.000242	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.24e-05	0.000241	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—DPYD—autistic disorder	2.23e-05	0.00024	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.19e-05	0.000236	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GPX1—autistic disorder	2.16e-05	0.000233	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.16e-05	0.000233	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.11e-05	0.000228	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.11e-05	0.000227	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.1e-05	0.000227	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.09e-05	0.000226	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.09e-05	0.000225	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CACNA1C—autistic disorder	2.07e-05	0.000223	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—DHFR—autistic disorder	2.07e-05	0.000223	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.06e-05	0.000222	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.06e-05	0.000222	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.05e-05	0.000221	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2e-05	0.000216	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—MTHFR—autistic disorder	2e-05	0.000215	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.99e-05	0.000215	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	1.91e-05	0.000206	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL2—autistic disorder	1.91e-05	0.000206	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—DHFR—autistic disorder	1.9e-05	0.000205	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—DHFR—autistic disorder	1.89e-05	0.000203	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	1.87e-05	0.000202	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL2—autistic disorder	1.87e-05	0.000202	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—autistic disorder	1.86e-05	0.0002	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TSC2—autistic disorder	1.82e-05	0.000196	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—LEP—autistic disorder	1.78e-05	0.000192	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—autistic disorder	1.78e-05	0.000192	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TSC2—autistic disorder	1.78e-05	0.000192	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.74e-05	0.000188	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—LEP—autistic disorder	1.74e-05	0.000188	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—autistic disorder	1.74e-05	0.000188	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.68e-05	0.000181	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PIK3CG—autistic disorder	1.68e-05	0.000181	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.64e-05	0.000177	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP19A1—autistic disorder	1.62e-05	0.000175	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APC—autistic disorder	1.61e-05	0.000173	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.61e-05	0.000173	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—POMC—autistic disorder	1.6e-05	0.000172	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.59e-05	0.000171	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.59e-05	0.000171	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APC—autistic disorder	1.57e-05	0.000169	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.57e-05	0.000169	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.55e-05	0.000167	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.53e-05	0.000165	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.52e-05	0.000164	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—COMT—autistic disorder	1.51e-05	0.000162	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTP1—autistic disorder	1.5e-05	0.000162	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MAOA—autistic disorder	1.49e-05	0.000161	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.49e-05	0.000161	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.49e-05	0.000161	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP19A1—autistic disorder	1.48e-05	0.000159	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.47e-05	0.000158	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.46e-05	0.000158	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAT—autistic disorder	1.46e-05	0.000157	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.44e-05	0.000155	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.43e-05	0.000154	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.4e-05	0.00015	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.39e-05	0.000149	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—COMT—autistic disorder	1.38e-05	0.000149	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTP1—autistic disorder	1.38e-05	0.000149	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLA2G4A—autistic disorder	1.38e-05	0.000148	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GSTM1—autistic disorder	1.38e-05	0.000148	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MAOA—autistic disorder	1.37e-05	0.000148	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—COMT—autistic disorder	1.37e-05	0.000148	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTP1—autistic disorder	1.37e-05	0.000147	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.37e-05	0.000147	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MAOA—autistic disorder	1.36e-05	0.000147	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAT—autistic disorder	1.34e-05	0.000145	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAT—autistic disorder	1.33e-05	0.000143	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—autistic disorder	1.32e-05	0.000142	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—autistic disorder	1.27e-05	0.000137	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GSTM1—autistic disorder	1.27e-05	0.000137	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.27e-05	0.000137	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLA2G4A—autistic disorder	1.26e-05	0.000135	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GSTM1—autistic disorder	1.26e-05	0.000135	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—MTHFR—autistic disorder	1.22e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—autistic disorder	1.21e-05	0.000131	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—autistic disorder	1.2e-05	0.00013	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.17e-05	0.000127	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.15e-05	0.000124	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—autistic disorder	1.13e-05	0.000122	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.13e-05	0.000122	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.12e-05	0.000121	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—MTHFR—autistic disorder	1.12e-05	0.000121	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTEN—autistic disorder	1.11e-05	0.00012	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—MTHFR—autistic disorder	1.11e-05	0.00012	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.1e-05	0.000119	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.1e-05	0.000119	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.06e-05	0.000115	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—autistic disorder	1.04e-05	0.000112	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.04e-05	0.000112	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—autistic disorder	1.03e-05	0.000111	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PIK3CG—autistic disorder	1.02e-05	0.00011	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—POMC—autistic disorder	9.73e-06	0.000105	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PIK3CG—autistic disorder	9.4e-06	0.000101	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PIK3CG—autistic disorder	9.32e-06	0.000101	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—POMC—autistic disorder	8.95e-06	9.65e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—POMC—autistic disorder	8.87e-06	9.57e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	8.64e-06	9.32e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	8.45e-06	9.11e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—autistic disorder	7.76e-06	8.37e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—autistic disorder	7.14e-06	7.7e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—autistic disorder	7.08e-06	7.63e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HRAS—autistic disorder	6.94e-06	7.48e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HRAS—autistic disorder	6.79e-06	7.32e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTEN—autistic disorder	6.77e-06	7.3e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6—autistic disorder	6.64e-06	7.16e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6—autistic disorder	6.49e-06	7e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTEN—autistic disorder	6.23e-06	6.71e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTEN—autistic disorder	6.17e-06	6.65e-05	CbGpPWpGaD
